Literature DB >> 11282082

Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells.

I Spyridopoulos1, P Mayer, K S Shook, D I Axel, R Viebahn, K R Karsch.   

Abstract

BACKGROUND: Ceramide is an important messenger of TNF- and lipid-induced apoptosis. We previously demonstrated the adverse effect of TNF in the process of reendothelialization as well as the dependence of its effect on cell-cycle regulation. The current study was designed to investigate the linkage between ceramide induced toxicity and growth arrest in human endothelial cells. METHODS AND
RESULTS: Cultured human arterial endothelial cells (HAEC) served as an in-vitro model to test the cellular effects of C2-ceramide (C2). C2-induced cell death in HAECs occurred time- and dose-dependently. The LD(50) in subconfluent cells was three times lower than in confluent cell layers (25 vs. 75 microM). C2 caused up to 70% inhibition of BrdU and [3H]thymidine incorporation at non-toxic concentrations as a result of G1 cell-cycle arrest. Downregulation of cyclin A and p21(Cip1/Waf1) protein expression was observed independently of C2-toxicity, while expression of other cell-cycle regulatory genes was not affected. Inhibition of cyclin A protein expression by sequence-specific antisense-oligonucleotides was paralleled by significant growth-inhibition. The protein phosphatase inhibitor okadaic acid induced endothelial cell proliferation, which was completely abrogated by C2. In contrast, aphidicolin-synchronized endothelial cells demonstrated elevated cyclin A levels along with 30% higher BrdU-incorporation and 70% less C2-toxicity. G1-arrested cells, however, showed significantly enhanced C2-toxicity, lack of cyclin A expression and induction of uncleaved caspase-3 (CPP32).
CONCLUSIONS: Ceramide abrogates endothelial cell proliferation independently of apoptosis or necrosis at low concentrations (<or=10 microM) through loss of cyclin A expression with subsequent G1 cell-cycle arrest. Synchronization of HAECs in S-phase with aphidicolin overcomes C2-induced G1-arrest and partially blocks ceramide toxicity. These findings demonstrate the dependence of ceramide toxicity on cell cycle regulation, suggesting a strong bidirectional relationship between cell-cycle control and cell death in vessel biology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282082     DOI: 10.1016/s0008-6363(01)00196-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Correlation of cytotoxic effect of transmembrane and secretory TNF-α to cell cycle.

Authors:  Xiang Li; Wenfang Shi; Yibing Hu; Yujing Yan; Yaqun Wu; Zhuoya Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

Review 2.  Involvement of ceramide in cell death responses in the pulmonary circulation.

Authors:  Irina Petrache; Daniela N Petrusca; Russell P Bowler; Krzysztof Kamocki
Journal:  Proc Am Thorac Soc       Date:  2011-11

3.  Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate.

Authors:  Padmavathi Bandhuvula; Zaiguo Li; Robert Bittman; Julie D Saba
Journal:  Biochem Biophys Res Commun       Date:  2009-01-23       Impact factor: 3.575

4.  Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.

Authors:  Uddalak Bharadwaj; Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  Mol Cancer       Date:  2011-08-31       Impact factor: 27.401

5.  C2-Ceramide-Induced Rb-Dominant Senescence-Like Phenotype Leads to Human Breast Cancer MCF-7 Escape from p53-Dependent Cell Death.

Authors:  Wen-Tsan Chang; Chang-Yi Wu; Yin-Chieh Lin; Min-Tsui Wu; Kai-Li Su; Shyng-Shiou Yuan; Hui-Min David Wang; Yao Fong; Yi-Hsiung Lin; Chien-Chih Chiu
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

6.  Long-term exposure to low levels of okadaic acid accelerates cell cycle progression in colonic epithelial cells via p53 and Jak/Stat3 signaling pathways.

Authors:  Lu Huang; Ji Gong; Yan Hu; Qiu-Lin Tan; Bo Liu; Xiao-Wen Yu; Xiang-Lin Hao; Qiao-Nan Guo
Journal:  Heliyon       Date:  2022-09-01

7.  KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.

Authors:  Victoria Emuss; Dimitrios Lagos; Arnold Pizzey; Fiona Gratrix; Stephen R Henderson; Chris Boshoff
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.